IBBvsPBE
iShares Biotechnology ETF against Invesco Dynamic Biotechnology & Genome ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBB | PBE | |
|---|---|---|
| Expense ratio | 0.45% | 0.58% |
| Assets | $10.6B | $398M |
| Net flow, 1 month | +$59M | +$90M |
| Net flow, 1 year | +$1.6B | +$88M |
| Return, YTD | +26.4% | +18.5% |
| Return, 1 year | +52.7% | +41.8% |
| Avg daily volume | 1.6M | 52K |
| Holdings | 221 | 31 |
| Listed | Feb 4, 2001 | Jun 22, 2005 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS